Literature DB >> 15144036

[Predictors of colectomy in patients with ulcerative colitis. A cohort analysis of 184 cases].

Arsenio Choquet1, Jesús K Yamamoto-Furusho, Edgardo Reyes, Takeshi Takahashi-Monroy, Florencia Vargas-Vorácková, Luis Uscanga.   

Abstract

BACKGROUND: At the present time procto-colectomy is the only potentially curative therapeutic measure for patients with ulcerative colitis (UC). Due to its morbidity and mortality, several prognostic indexes have been proposed to identify subjects in whom surgery could be beneficial. However, they have limited availability or they are very cumbersome for the individual patient. AIM: To analyze demographic, clinical and biochemical variables in a group of 184 Mexican patients with UC in order to identify predicting factors for procto-colectomy. PATIENTS AND METHODS: Subjects were divided into two groups: A. Those in whom a procto-colectomy was performed (n = 52) and B. Patients on medical treatment in = 132). Continuous variables were analyzed by means of the Student's t test and categorical variables by means of chi-square statistic. A multivariate analysis was performed using logistic regression.
RESULTS: The main indication for surgery was failure to medical treatment (78%). Procto-colectomy was elective in 28 cases and an emergency procedure in 14 (7 failures to medical treatment, 4 colonic perforations, 2 toxic megacolons and 1 uncontrolled hemorrhage). All operated subjects had pancolitis and showed more bloody bowel movements per day (> 10), fever (> 38.5 degrees C), tachycardia, hipoalbuminemia and hospitalizations. Only hypoalbuminemia in subjects with universal colitis was consistently associated to procto-colectomy.
CONCLUSION: Pancolitis, hypoalbuminemia and previous hospitalizations were the strongest predictors of procto-colectomy in our cohort. Thus, serum protein determinations can be useful in patients with universal UC to decide surgical therapy.

Entities:  

Mesh:

Year:  2004        PMID: 15144036

Source DB:  PubMed          Journal:  Rev Invest Clin        ISSN: 0034-8376            Impact factor:   1.451


  4 in total

1.  Corticosteroid therapy in ulcerative colitis: Clinical response and predictors.

Authors:  Jin Li; Fan Wang; Hong-Jie Zhang; Jian-Qiu Sheng; Wen-Feng Yan; Min-Xing Ma; Ru-Ying Fan; Fang Gu; Chuan-Feng Li; Da-Fan Chen; Ping Zheng; Yu-Pei Gu; Qian Cao; Hong Yang; Jia-Ming Qian; Pin-Jin Hu; Bing Xia
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

2.  Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis.

Authors:  Marco M Hefti; David B Chessin; Noam H Harpaz; Randolph M Steinhagen; Thomas A Ullman
Journal:  Dis Colon Rectum       Date:  2009-02       Impact factor: 4.585

3.  Incidence and prevalence of inflammatory bowel disease in Mexico from a nationwide cohort study in a period of 15 years (2000-2017).

Authors:  Jesús K Yamamoto-Furusho; Andrea Sarmiento-Aguilar; Joel J Toledo-Mauriño; Katya E Bozada-Gutiérrez; Francisco J Bosques-Padilla; Manuel A Martínez-Vázquez; Virgilio Marroquín-Jiménez; Rosalva García-Figueroa; Christian Jaramillo-Buendía; Rosa M Miranda-Cordero; Jesús A Valenzuela-Pérez; Yolanda Cortes-Aguilar; Janett S Jacobo-Karam; Emilio F Bermudez-Villegas
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

4.  Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study.

Authors:  Agustín Ciapponi; Sacha Alexis Virgilio; Mabel Berrueta; Natalie Claire Soto; Álvaro Ciganda; Moisés Freddy Rojas Illanes; Briseida Rubio Martinez; Johana Gamba; Carlos Arturo González Salazar; José Nicolás Rocha Rodríguez; Bruno Scarpellini; Ana María Bravo Perdomo; Gerardo Machnicki; Leandro Aldunate; Juan De Paula; Ariel Bardach
Journal:  PLoS One       Date:  2020-01-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.